Labshake search
Citations for Stemcell Technologies :
151 - 200 of 4374 citations for Dengue Virus Serotype 2 Envelope Protein Insect Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2023Quote: ... differentiating cells were confluent again and split 1:3-1:4 into Step 2 differentiation medium: BrainPhys Neuronal Medium (STEMCELL Technologies, cat# 05790), 1X N2 ...
-
bioRxiv - Molecular Biology 2023Quote: RNA samples were extracted from differentiated NPCs or undifferentiated NPCs treated for 2 hrs with STEMdiff™ Forebrain Neuron Differentiation medium (Stem Cell Technologies) for differentiated NPCs ...
-
bioRxiv - Genomics 2020Quote: ... with 2 mM L-Glutamine (Stemcell Technologies), 1x 2-Mercaptoethanol (Millipore) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 µM XAV939 (StemCell Technologies, 72674). TPM was changed every day from day 3 to day 7 ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% SM1 (Stemcell Technologies; 05792), 5 mM L-Glutamine (Stemcell Technologies ...
-
bioRxiv - Genetics 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 2 mM EDTA (Stemcell Technologies) and pooled for antibody staining.
-
bioRxiv - Cell Biology 2022Quote: ... supplemented with 2% SM1 (StemCell Technologies #05711), 40 μg/mL gentamycin and 2.5 μg/mL Amphotericin B medium ...
-
bioRxiv - Pathology 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Molecular Biology 2022Quote: ... & 300 IU/mL IL-2 (STEMCELL Technologies). T cells were seeded at 2 × 106 cells/mL (typically 10×106 cells per well of a 6-well plate ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... heparin solution (2 mg/mL, STEMCELL Technologies), recombinant bFGF (20 ng/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Cancer Biology 2023Quote: ... heparin (2 mg/mL, STEMCELL Technologies 07980), 1% penicillin/streptomycin ...
-
bioRxiv - Cell Biology 2023Quote: ... and 2.5µM of IWP-2(Stemcell Technologies). Rudibaugh2 organoid media was supplemented with 100ng/mL SHH(VWR ...
-
bioRxiv - Cell Biology 2024Quote: ... 2 mg/mL DNase I (STEMCELL Technologies), and 5 mg/mL (adult ...
-
bioRxiv - Developmental Biology 2024Quote: ... in APEL 2 base medium (Stemcell Technologies). On day 3 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 2 μg/ml heparin (Stemcell Technologies, 07980), and penicillin-streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 2% SM1 (STEMCELL Technologies, 05792), 5 mM L-glutamine (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2022Quote: ... medium was refreshed every 7 days by replacing half of the medium with Brainphys neuronal medium supplemented with 2% NeuroCult SM1 neuronal supplement (Stem cell technologies, Köln, Germany) and 1% pen/strep (BP-complete medium).
-
bioRxiv - Cancer Biology 2023Quote: ... Isolated T cells were seeded at a density of 1 x 106 cells/mL in RPMI medium supplemented with 10 ng/mL human recombinant interleukin 2 (IL2, Stemcell Technologies, Cat. No. 78145.2), 1µg/ml anti-human CD3 antibody (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... CD4+ T cells were purified from donor 2 LRS cone using a Rosettesep human CD4+ enrichment cocktail (Stemcell Technologies, Cambridge, MA; Supplementary Fig. 1B). 5×106 CD4+ T cells from donor 2 were cultured with 5×105 DCreg from donor 1 in X-vivo media for 5 days ...
-
bioRxiv - Developmental Biology 2023Quote: AGMs of E10.5 embryos were dissected in PBS with 7% fetal calf serum (FCS) and penicillin/streptomycin (100 U/mL) and cultured as explants for 2 days in medium consisting of Stemspan (Stem Cell Technologies, cat # 09600), 20% fetal calf serum ...
-
bioRxiv - Neuroscience 2023Quote: ... 1.5 nM bone morphogenetic protein 4 (BMP4, Stemcell technologies) was added to the medium for another three days ...
-
bioRxiv - Developmental Biology 2022Quote: ... replated at a density of 1.58 × 105 cells/cm2 in Vitronectin XF-coated 24 well plate into cardiomyocyte media (RPMI, 2% B27 supplement plus insulin [Life Technologies Australia, Cat.#17504001], 10% FBS, and 10 µM Y-27362 ROCK inhibitor [Stem Cell Technologies, Cat.#72308]) and cultured overnight ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Cancer Biology 2019Quote: ... 2 μg/mL Heparin (StemCell Technologies, Cat 07980), 1× antibiotic-antimicotic (Life Technologies Gibco ...
-
bioRxiv - Genetics 2022Quote: ... 2 μM doxycycline and CloneR supplement (StemCell Technologies) to enhance the viability of single cells ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% NeuroCult SM1 supplement (STEMCELL Technologies) and 1% penicillin/streptomycin (Gibco) ...
-
bioRxiv - Cell Biology 2021Quote: ... containing 2% NeuroCult SM1 supplement (StemCell Technologies, 05711), 1% L-glutamine (Corning ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM of XAV939 (STEMCELL Technologies, #72674) were added to induce cerebro-cortical differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM of XAV939 (#72674, StemCell Technologies). The medium was changed daily until day 11 ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% NeuroCult™ SM1 (STEMCELL Technologies, Cat# 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2×105 hDR4+ HSCs (purchased from Stemcell Technologies Inc ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 μMY27632 (Stemcell Technologies, 129830-38-2)) on day 0 ...
-
bioRxiv - Genetics 2023Quote: ... the top 40% of ATTO-550 positive cells were sorted as single-cells into individual wells of two 96-well plates with different combination of CellAdhere Laminin-521 (STEMCELL Technologies, Cat#77004, (2 μg/cm2)) or Vitronectin (0.5 μg/cm2) ...
-
bioRxiv - Neuroscience 2021Quote: ... placed in a stereotaxic frame and injected with either 100,000 hNSCs per side (2 μl/injection) or vehicle (2 μl HBSS with 20 ng/ml epidermal growth factor [STEMCELL Technologies, #78003] and human fibroblast growth factor [STEMCELL ...
-
IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenancebioRxiv - Cell Biology 2023Quote: ... Briefly, PB was collected in FACS buffer (PBS, 2 % FBS, 2 mM EDTA) supplemented with 0.0004 % heparin solution (STEMCELL Technologies Inc.). RBCs was removed by incubation at 37 °C for 25 minutes with 1 % Dextran solution in PBS ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were centrifuged at 200 x g for 2 min and resuspended in neural media (NM; Supplementary Table 2) supplemented with 0.02 µg/mL FGF2 (StemCell Technologies, #78003) and 0.02 µg/mL EGF (StemCell Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... Embryoid body media (EBM) was used for days 2 to 11 (Supplementary Table 2) and supplemented with 10 µM SB431542 (Stemcell Technologies, #72234), 0.1 µM LDN193189 (MedChemExpress ...
-
bioRxiv - Developmental Biology 2023Quote: ... Explants were then cultured in suspension in DMEM for 2 hours at 37°C with a 1/250 dilution from 100 mM stock solution or Dispase II (Stem Cell Technologies; #07923, at 0.2 U/mL).
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 2 mg/mL heparin (#07980; STEMCELL Technologies) on 10 μg/mL human plasma fibronectin (#FC010 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Fibroblast Growth Factor-2 (FGF2, StemCell Technologies Cat#78134.1), Vascular Endothelial Growth Factor-A (VEGF-165 ...
-
bioRxiv - Cancer Biology 2020Quote: ... supplemented with 2 µg/ml heparin sulfate (STEMCELL Technologies) or SFM supplemented with 20 ng/ml human recombinant epidermal growth factor (hEGF ...